APPLICATION
ANDA210576
TYPE
ANDA
ORIGINAL APPROVAL
2018-10-17
LATEST ACTION
2024-08-22
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
ISOPROTERENOL HYDROCHLORIDEPrescription
ISOPROTERENOL HYDROCHLORIDE 0.2MG/ML · INJECTABLE · INJECTION
Approval history
2024-08-22Labeling · Supplement 8 · standardAP
2018-10-17UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.